Neutrophil-to-lymphocyte ratio as a predictor for cardiovascular diseases: a cohort study in Tianjin, China

Yuxin Zhao1,2, Shuaixiang Zhang1,2, Yue Yi1,2

  • 1Department of Epidemiology and Biostatistics, School of Public Health, Tianjin Medical University, Tianjin, China.

Insights

Higher neutrophils-to-lymphocyte ratio (NLR) is linked to increased cardiovascular disease (CVD) risk. This study found elevated NLR significantly associated with higher incidence of CVDs, myocardial infarction, and ischemic stroke.

Area of Science:

  • Cardiology
  • Inflammation Research
  • Epidemiology

Background:

  • The neutrophils-to-lymphocyte ratio (NLR) is an emerging inflammatory marker.
  • Elevated NLR has been implicated in various cardiovascular diseases (CVDs).
  • Understanding the association between NLR and CVD risk in diverse populations is crucial.

Purpose of the Study:

  • To investigate the relationship between baseline neutrophils-to-lymphocyte ratio (NLR) and the incidence of cardiovascular diseases (CVDs).
  • To evaluate NLR as a predictive marker for total CVDs, myocardial infarction, and ischemic stroke.

Main Methods:

  • A prospective cohort study involving 4667 participants over 40 years old, free of CVDs at baseline.
  • NLR values were assessed at baseline and analyzed using Cox proportional hazards models.
  • Confounding factors were adjusted using LASSO regression.

Main Results:

  • A total of 150 CVD events occurred during 13,691 person-years of follow-up.
  • Higher baseline NLR tertiles showed a significant trend towards increased CVD incidence (p=0.019).
  • Adjusted Cox models indicated NLR (continuous) was associated with increased risk of total CVDs (HR 1.10), myocardial infarction (HR 1.12), and ischemic stroke (HR 1.21). Participants in the highest NLR tertile had significantly higher risks for CVDs and myocardial infarction compared to the lowest tertile.

Conclusions:

  • Elevated neutrophils-to-lymphocyte ratio is a significant independent predictor of cardiovascular disease risk.
  • NLR may serve as a valuable, easily accessible biomarker for stratifying CVD risk in clinical practice.
  • Further research should explore the underlying mechanisms linking NLR to cardiovascular events.